Among the several mechanisms known to be involved in the establishment and maintenance of immunological tolerance, the activity of CD4 clinical targets and still elusive regulatory T cell-specific markers. Importantly, these genes may also modulate susceptibility to autoimmune-disease.
Summary
Among the several mechanisms known to be involved in the establishment and maintenance of immunological tolerance, the activity of CD4 strains. We demonstrate that distinct levels of phenotypically identical regulatory T cells develop with similar kinetics in the studied mice. Our experimental data on congenic mousestrains indicate that differences are not caused by the distinct MHC haplotypes of the inbred mouse strains. Moreover, the responsible loci act in a thymocyte intrinsic manner, confirming the latter conclusion. We have not found any correlation between thymic and peripheral levels
Introduction
Immune-tolerance is established by a variety of mechanisms acting in primary lymphoid organs during lymphopoiesis and in so-called "peripheral" lymphoid organs during the activation or differentiation-phase of mature lymphocytes [1] . Among the several mechanisms known to be involved, active tolerance (i.e. mediated by regulatory or suppressor lymphocytes) has incited great interest because of its potential in treatment of diseases as varied as autoimmune-disorders and cancer, as well as in transplantation [2] [3] [4] . The best studied regulatory T cell subset is of CD4 + CD25 + phenotype. These cells were discovered because of their crucial role in the inhibition of multiorgan autoimmune-disorder induced by thymectomy of mice at day three of life [5] . Later, these cells were shown to inhibit inflammatory bowel disease, to fine-regulate immunity to pathogens, to inhibit anti-tumor immunity, and to protect the fetus from maternal immune aggression [6] [7] [8] [9] We here present data indicating the existence of genetic polymorphisms causing quantitative differences in regulatory T lymphocyte development in common laboratory mouse-strains.
We show that genes outside the MHC and acting in a thymocyte intrinsic manner modulate intrathymic differentiation of regulatory T lymphocytes. Ultimate identification of the responsible loci should prove important for the analysis of thymic regulatory T cell lineage choice and selection, may allow for identification of still elusive regulatory T cell-specific markers, and may yield more insight in mechanisms modulating susceptibility to autoimmune-disease.
Results

Distinct proportions of CD25 + regulatory T cells in thymus of different inbred-mouse strains
We figure 1E , substantially higher percentages of FoxP3-expressing cells were observed in DBA/2 and SJL mice than in B6
animals, confirming and extending our data on CD25 high thymocytes.
We also analyzed levels of regulatory T cells in the periphery. As shown in figure 1F , we failed to observe a direct correlation of CD4 + CD25 + percentages in thymus versus PBMC.
Similar data were obtained for secondary lymphoid organs (not shown).
Distinct proportions of thymic regulatory T cells are caused by differences in their differentiation
Distinct proportions of regulatory CD25 + cells among CD4SP thymocytes may be due to differences in their development or in thymic retention of mature thymocytes. To study the former possibility, we analyzed the kinetics of regulatory T cell development by measuring the appearance of BrdU + cells in mice continuously fed with this nucleotide analog in their drinking water. As shown in figure 2, more CD4 + CD25 + regulatory T lymphocytes differentiated from their dividing precursors in SJL mice than in B6 thymi. This result establishes that significant differences in thymic differentiation of these cells exist between these two mouse strains. However, it formally does not exclude the possibility that differences in thymic retention of regulatory T cells may also exist.
Distinct regulatory T cell proportions are not caused by differences in MHC haplotype
We next studied if the MHC haplotypes of the distinct mouse strains analyzed were responsible for the quantitative differences in thymic regulatory T cell generation. SJL mice have significantly higher percentages of CD25 + CD4SP thymocytes than B10 mice (Fig. 3A) . (Fig. 3B) . Therefore, the distinct MHC class I and II haplotypes of these mouse strains are not responsible for the different proportions of thymic regulatory T cells, and the genetic loci involved are not linked to the MHC.
Thymocyte-intrinsic factors determine the distinct proportions of regulatory T cells
Differences in the development of regulatory T cells may be due to thymocyte-intrinsic factors or to variations in the thymic microenvironment. To distinguish between these two possibilities we generated mixed bone marrow chimeras in which thymocytes derived from the different donor mouse-strains differentiate simultaneously in the same thymic microenvironment. (B6 x DBA/2)F 1 (B6D2F1) hosts were lethally irradiated and reconstituted with a 1:1 mixture of B6 and DBA/2 bone-marrow cells (B6 + DBA/2  B6D2F1 chimeras).
Six weeks later the thymi of these chimeras were analyzed by flow-cytometry. As shown in figures 4A and C, among B6-derived cells from these mixed chimeras the same (lower)
proportion of thymic regulatory T cells was found as in the parent strain. Among DBA/2-derived thymocytes the (higher) percentage of CD25 + cells in the CD4SP population was similar to that found in the DBA/2 parent strain. In B6 + SJL  B6SJLF1 mixed bonemarrow chimeras we observed a proportion of B6-derived regulatory T cells similar to that observed in the parent strain (Figs. 4B and C) [48] [49] [50] . Very closely linked is the gene encoding CTLA-4, which is critically involved in regulatory T cell function [51] . Moreover, Ctla-4 is a diabetes susceptibility gene in humans [52] , and has been reported to modulate thymic negative selection of effector T cells in mice [53] . A third gene within the Idd5 locus, ICOS, is also known to play an important role in regulatory T cell function [18, 54] . However, none of these genes has thus far been shown to modulate regulatory T cell development.
Identification of the responsible gene(s) may also reveal entirely novel factors critically involved in regulatory T cell development and function, and thus allow for better understanding of these processes. Such factors may also constitute unique markers for regulatory T cells, which have thus far proven elusive, and become clinical targets. Whatever the precise explanation for genetic modulation of regulatory T cell development, it may have important consequences for regulatory T cell repertoire and/or function and thus modulate susceptibility to e.g. autoimmune diseases. It would therefore be important to assess regulatory T cell differentiation in autoimmune-prone animals, and to identify responsible genetic loci. 
Materials and Methods
Mice
Antibodies
The following antibodies and secondary reagents were used for phenotypic analysis: PE-Cy7 or APC-labeled anti-CD4 (GK1.5), FITC or APC-labeled anti-CD8 (53.6.7), APC or PE- Biotin-labeled anti-GITR was purchased from R&D, Lille, France.
Bone-marrow chimeras
Bone-marrow from femurs and tibias was collected in DMEM medium supplemented with 10% FCS. Thy1 + cells were eliminated using AT83 hybridoma supernatant and rabbit complement (Saxon Europe, Suffolk, UK). Cells from each donor were injected intravenously into lethally γ-irradiated hosts (8.5 Gy; 137 Cs source, 6.3 Gy/min) that were kept on antibiotic-containing water (0.2% of Bactrim; Roche) for the complete duration of the experiment (6 weeks).
Flow cytometry
Thymocytes or peripheral blood mononuclear cells were incubated 30 min on ice in 2.4G2
(anti-FcγR mAb) hybridoma supernatant. Cells were then incubated 20 min with saturating concentrations of Abs. Intracellular Foxp3-staining on CD8-depleted thymocytes (using anti-CD8 mAb 31M and complement) was performed according to the instructions of the manufacturer. Labeled cells were analyzed using a FACSCalibur cytometer and CellQuest software (BD Biosciences, San Diego,CA).
BrdU incorporation studies
Mice were continuously exposed to the thymidine analogue bromodeoxyuridine (0.8mg/mL) in their drinking water. Extracellular staining of thymocytes with mAbs against CD4, CD8
and CD25 was performed as described above. Cells were fixed, permeabilized and stained with FITC-labelled anti-BrdU using the BrdU Flow Kit (BD Pharmingen, Heidelberg, Germany).
Statistical analysis
Statistical significance of the data was analyzed using Student's t test (*: p<0.05; **: p<0.01; ***: p<0.001). Statistical significance was calculated using Student's t-test (**p<0.01, ***p<0.001). 
